Next-generation tumor organoids: a functional integration framework for advancing precision oncology

Abstract Tumor organoids are three-dimensional (3D), self-organizing cultures that have become a central experimental platform in cancer research and translational medicine. Their value lies in preserving genetic heterogeneity, reproducing patient-specific phenotypes, and supporting functional drug sensitivity testing. Yet conventional organoids remain constrained: they reconstruct the tumor microenvironment (TME) poorly, capture spatial heterogeneity and dynamic physiology incompletely, and still lack clinical standardization. Recent advances in gene editing, immune and stromal co-culture, single-cell and spatial multi-omics, 3D bioprinting, and organ-on-a-chip systems now offer routes past these bottlenecks. Most of the literature, however, treats them piecemeal, pairing organoids with one technology at a time, and rarely articulates the logic that connects them. This review proposes a functional integration framework that organizes these technologies into four layered capabilities: a genetic engineering layer, a cellular ecosystem layer, a spatial and architectural layer, and a dynamic systems layer. We show how each layer brings organoids closer to the true complexity of tumors in vivo, then use the framework to discuss applications in mechanistic cancer research, drug discovery, immunotherapy modeling, and precision clinical decision support. We close with a critical reading of the clinical-translation evidence, the key bottlenecks, and future prospects, and introduce the forward-looking concept of a “functional digital twin.”